UASt regulatory sequences drive expression of an inverted repeat.
Expression of AldGD17138 under the control of either Scer\GAL4repo-M1B or Scer\GAL4elav-C155 results in severely reduced lifespan at 25[o]C, with 50% survival at 8 and 12 days respectively (compared to approximately 60 days in controls).
Expression of AldGD17138 under the control of Scer\GAL4elav-C155 does not result in any overt neuropathological defect.
Flies expressing AldGD17138 under the control of Scer\GAL4repo-M1B show vacuolisation in the central brain and optic lobes.
Depending on the insertion line used, expression under the control of Scer\GAL4Mef2.PR can result in flightless flies or early larval lethality.
Expression under the control of Scer\GAL4Mef2.PR results in split larval body wall muscles.
Expression under the control of Scer\GAL4Mef2.PR results in wild-type sarcomeres in the larval body wall muscles.